The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals' Journavx for short-term pain that often follows surgery or injuries.
The FDA has approved Vertex Pharmaceuticals’ Journavx, a new pain medication designed to reduce the risk of addiction and overdose associated with opioids. Intended for short-term pain after surgeries ...
A new type of painkiller aimed at treating pain from an injury or surgery has been approved by the US Food and Drug Administration (FDA). The drug suzetrigine, also known by its brand name Journavx, ...
On Thursday, the Food and Drug Administration approved the non-opioid pain relievers from Vertex Pharmaceuticals, a new ...
The US Food and Drug Administration has approved the first-ever non-opioid pain reliever in more than two decades.According ...
Will people with acute pain want a new painkiller whose list price is $15.50 a pill when a generic prescription drug is at ...
There are various everyday issues that not only interrupt your sleep but are distressing as well. And so, to get rid of these conditions, there are a few expert-backed sleeping positions that can help ...
The drug is called Journavx and doctors believe it has no potential for addiction and dependence.
In today’s time of endless scrolling and spending a lot of time on the internet, experts say technology addiction—just like other dependencies—is a real thing. While it may not be recognised as a ...
Vertex Pharmaceuticals’ suzetrigine gets US FDA approval for treatment of adults with moderate-to-severe acute pain: Boston Saturday, February 1, 2025, 14:00 Hrs [IST] Vertex Ph ...